CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 453226-453587 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T35088","span":{"begin":0,"end":361},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We compared relative risk of hospitalization/ED recurrence from day 31-180 (Cox proportional hazards regression, covariates=sex, age, current and prior asthma medications, prior oral corticosteroid and short-acting 2 -adrenergic agonist use, initial type of index event) for patients receiving nebulized ICS vs other ICS by age groups (0-4 years and 5-8 years)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T40","span":{"begin":0,"end":361},"obj":"Sentence"}],"text":"We compared relative risk of hospitalization/ED recurrence from day 31-180 (Cox proportional hazards regression, covariates=sex, age, current and prior asthma medications, prior oral corticosteroid and short-acting 2 -adrenergic agonist use, initial type of index event) for patients receiving nebulized ICS vs other ICS by age groups (0-4 years and 5-8 years)."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4510","span":{"begin":152,"end":158},"obj":"Disease"},{"id":"T4511","span":{"begin":304,"end":307},"obj":"Disease"},{"id":"T4512","span":{"begin":317,"end":320},"obj":"Disease"}],"attributes":[{"id":"A4510","pred":"mondo_id","subj":"T4510","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A4511","pred":"mondo_id","subj":"T4511","obj":"http://purl.obolibrary.org/obo/MONDO_0016575"},{"id":"A4512","pred":"mondo_id","subj":"T4512","obj":"http://purl.obolibrary.org/obo/MONDO_0016575"}],"text":"We compared relative risk of hospitalization/ED recurrence from day 31-180 (Cox proportional hazards regression, covariates=sex, age, current and prior asthma medications, prior oral corticosteroid and short-acting 2 -adrenergic agonist use, initial type of index event) for patients receiving nebulized ICS vs other ICS by age groups (0-4 years and 5-8 years)."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T2491","span":{"begin":152,"end":158},"obj":"Phenotype"}],"attributes":[{"id":"A2491","pred":"hp_id","subj":"T2491","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"We compared relative risk of hospitalization/ED recurrence from day 31-180 (Cox proportional hazards regression, covariates=sex, age, current and prior asthma medications, prior oral corticosteroid and short-acting 2 -adrenergic agonist use, initial type of index event) for patients receiving nebulized ICS vs other ICS by age groups (0-4 years and 5-8 years)."}